If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Wednesday broker round-up UPDATE

Wed, 04th Dec 2013 09:21
Afren: FinnCap lowers target price from 170p to 165p and downgrades to hold.Amlin: Espirito Santo upgrades to buy with a target price of 509p.Betfair: Citi raises target price from 1150p to 1225p maintaining a buy recommendation.Brewin Dolphin: Canaccord Genuity increases target price from 285p to 304p upgrading from hold to buy.British Sky Broadcasting: Nomura ups target price from 850p to 870p and keeps a reduce rating.Bunzl: Cantor Fitzgerald increases target price from 1070p to 1260p, but still recommends selling.Cairn Energy: Liberum Capital cuts target price from 384p to 355p and maintains a buy recommendation.Compass Group: RBC Capital ups target price from 930p to 950p and reiterates an outperform rating.Consort Medical: Jefferies raises target price from 910p to 1000p and keeps a buy recommendation. Investec ups target price from 966p to 1005p keeping a buy recommendation. Canaccord Genuity takes target price from 895p to 980p and reiterates a buy recommendation.Daily Mail & General Trust: Nomura increases target price from 440p to 900p upgrading to neutral.Experian: Nomura takes target price from 1215p to 1250p retaining a buy recommendation.Faroe Petroleum: FinnCap upgrades to buy with a target price of 145p.Genel Energy: Credit Suisse increases target price from 1296p to 1430p and reiterates a buy recommendation.Genus: N+1 Singer reduces target price from 1357p to 1255p maintaining a hold recommendation.Greencore: Numis ups target price to 184p and keeps a hold recommendation.Greene King: Citi raises target price from 900p to 985p and leaves its buy recommendation unaltered.HICL Infrastructure: RBC Capital shifts target price from 130p to 133p upgrading to outperform.IMI: Investec increases target price from 1550p to 1640p upgrading from hold to buy.Informa: Nomura takes target price from 600p to 660p and stays with its buy recommendation.Innovation Group: Panmure Gordon shifts target price from 45p to 46p and retains a buy recommendation.ITV: Nomura moves target price from 210p to 220p and keeps a buy recommendation.M&C Saatchi: N+1 Singer upgrades to buy with a target price of 357p.Micro Focus International: HSBC ups target price from 800p to 850p keeping a hold recommendation.Ophir Energy: Liberum Capital upgrades to hold with a target price of 325p.Pearson: Nomura ups target price from 1100p to 1140p maintaining a reduce rating. Societe Generale moves target price from 1290p to 1300p and retains its hold recommendation.Petra Diamonds: RBC Capital shifts target price from 150p to 160p, while its outperform rating remains kept.Polar Capital Holdings: Canaccord Genuity upgrades from hold to buy with a target price of 550p. Numis downgrades from add to hold with a target price of 518p.Premier Oil: FinnCap lowers target price from 420p to 405p, while its buy recommendation remains unchanged.Randgold Resources: Investec upgrades to buy with a target price of 5095p.Reckitt Benckiser: UBS reduces target price from 5210p to 4550p and downgrades from buy to sell.Reed Elsevier: Nomura takes target price from 900p to 975p and stays with its buy recommendation.Rightmove: Nomura initiates with a target price of 2900p and a buy recommendation.Safestore Holdings: Investec raises target price from 140p to 196p reiterating a buy recommendation.Sage Group: Panmure Gordon ups target price from 333p to 341p and reiterates a hold recommendation. Numis upgrades from hold to add with a target price of 383p.Salamander Energy: FinnCap lowers target price from 145p to 140p staying with its buy recommendation.Speedy Hire: RBC Capital cuts target price from 70p to 51p downgrading to neutral.St Modwen Properties: Numis raises target price from 280p to 401p, while leaving its add rating unchanged.UBM: Nomura cuts target price from 800p to 740p downgrading to neutral.Vodafone Group: UBS ups target price from 245p to 260p retaining its buy recommendation.WPP Group: Nomura raises target price from 1450p to 1600p and reiterates a buy recommendation.

Related News

LONDON MARKET CLOSE: FTSE 100 up as DAX hits record high in Frankfurt
2 days ago

LONDON MARKET CLOSE: FTSE 100 up as DAX hits record high in Frankfurt

(Alliance News) - The FTSE 100 closed a winning week on the front foot, while the DAX 40 hit a new best level, as fears of a US rate increase faded.

LONDON BROKER RATINGS: Shore raises Close Bros, cuts Capricorn Energy
2 days ago

LONDON BROKER RATINGS: Shore raises Close Bros, cuts Capricorn Energy

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.